![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Simplification to Stribild vs Continuation of RTV-boosted DRV with
FTC and TDF in Virologically Suppressed HIV Adults:
A STRATEGY-PI Subgroup Analysis
|
|
|
Reported by Jules Levin
HIV Drug Therapy
November 2-6, 2014
Glasgow, UK
J Arribas1, G Rizzardini2, K Arastéh3, C Zurawski4, C Dietz5, D Pontani6, W Garner6, and T Nguyen6
1Hospital La Paz, IdiPAZ, Madrid, Spain; 2Luigi Sacco Hospital, Milan, Italy; 3EPIMED, Vivantes Auguste-Viktoria-Klinikum, Berlin, Germany;
4Atlanta Infectious Diseases Group, Atlanta, Georgia, USA; 5Kansas City Free Health Clinic, Kansas City, MO, USA;
6Gilead Sciences, Inc., Foster City, CA, USA
![Glascow1.gif](../images/110714/110714-1/Glascow1.gif)
![Glascow2.gif](../images/110714/110714-1/Glascow2.gif)
![Glascow3.gif](../images/110714/110714-1/Glascow3.gif)
![Glascow4.gif](../images/110714/110714-1/Glascow4.gif)
![Glascow5.gif](../images/110714/110714-1/Glascow5.gif)
![Glascow6.gif](../images/110714/110714-1/Glascow6.gif)
![Glascow7.gif](../images/110714/110714-1/Glascow7.gif)
![Glascow8.gif](../images/110714/110714-1/Glascow8.gif)
![Glascow9.gif](../images/110714/110714-1/Glascow9.gif)
![Glascow10.gif](../images/110714/110714-1/Glascow10.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|